NTI-tss Plus Splint Therapy Significantly Reduces Migraine Pain in new BMC Neurology Study CHICAGO, June 10, 2022 /PRNewswire-PRWeb/ -- New research has been published demonstrating the effectiveness ...
For 30 days, migraineurs were randomized to an FDA-approved dental device to help jaw clenching or a placebo device. Findings of a randomized-controlled trial suggest intense nocturnal jaw clenching ...
September 18, 2009 (Philadelphia, Pennsylvania) — A small intraoral dental device augments the efficacy of valproic acid (VPA; Depakote, Abbott, and others) for the treatment of migraine or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback